Sort
10,829 grants matching “car t”
MOLECULAR GENETICS OF CARDIAC MYXOMAS (CARNEY COMPLEX)
$430,850Weill Medical College Of Cornell Univ · R01 · FY2002 · HL
Synthetic Studies Related to Cancer Research/Treatment
$430,815Paul Wender · Stanford University · R01 · FY2023 · CA
Programming Long Term Durable HIV-1 Specific T cell Responses
$430,739E. John Wherry · University Of Pennsylvania · U19 · FY2015 · AI
Synthetic Studies Related to Cancer Research/Treatment
$430,697Paul Wender · Stanford University · R01 · FY2025 · CA
Universality in random matrices and integrable systems: asymptotic analysis via Riemann-Hilbert and d-bar methods
$430,673Kenneth D T-R McLaughlin · University Of Arizona · · FY2008 · MPS
Niche-induced Signaling in Progenitor B Cell Development
$430,650Leslie Eric Silberstein · Boston Children'S Hospital · R01 · FY2012 · HL
Efficient estimation of auditory sensitivity and cognitive status using spoken-digit tests.
$430,438Gary R Kidd · Communication Disorders Technology, Inc · R33 · FY2021 · DC
What fuels CAR T-cell serial killing
$430,406Roderick O'Connor · University Of Pennsylvania · R01 · FY2023 · CA
Immune cell control of ovarian cancer
$430,385Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Facile screening for esophageal cancer in LMICs
$430,285Stephen J Meltzer · Johns Hopkins University · UG3 · FY2017 · CA
Ameliorating off-target toxicities of CAR T cells by engineering NOT gates
$430,107Wendell A Lim · University Of California, San Francisco · R01 · FY2024 · CA
Regulation of CD8+T cells by Zbtb42
$429,966Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2025 · CA
An integrated polymeric carrier for subunit cancer vaccines
$429,683Suzie H Pun · University Of Washington · R01 · FY2021 · CA
Project 2: Combined CAR-T cell therapy
$429,640Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA
Pre- to Post-Immigration Drinking and Driving among Recent Latino Immigrants: Examining Opportunities for Intervention
$429,275Eduardo O Romano · Pacific Institute For Res And Evaluation · R01 · FY2021 · AA
Engineering Natural Killer Cells to Target Acute Myeloid Leukemia with HLA-DR Loss
$429,000Jianming Xie · Western University Of Health Sciences · R15 · FY2025 · CA
Exploring Age Differences in Patient Reported Cognitive Function Trajectories among Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T-cell patients and Linking Two Key Measures
$429,000Rachel Nicole Cusatis · Medical College Of Wisconsin · R21 · FY2023 · AG
Targeting miRNA-loaded exosomes to HNSCC with Dsg2-directed scFv fusion proteins
$429,000My Georgia Mahoney · Thomas Jefferson University · R21 · FY2024 · DE
Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgaris
$429,000Aimee S Payne · University Of Pennsylvania · R01 · FY2023 · AR
Physical Resistance to Immune Cell Attack by the Cellular Glycocalyx
$428,910Matthew J Paszek · Cornell University · R01 · FY2024 · CA
Niche-induced Signaling in Progenitor B Cell Development
$428,750Leslie Eric Silberstein · Boston Children'S Hospital · R01 · FY2010 · HL
Enhanced imaging and treatment of aggressive subtypes of prostate cancer
$428,718Martin G Pomper · Ut Southwestern Medical Center · R01 · FY2024 · CA
Therapeutic Manufacturing Shared Resource
$428,687Zita Mears · Fred Hutchinson Cancer Center · P30 · FY2025 · CA
CAREER: Towards Non-Conservative Learning-Aided Robustness for Cyber-Physical Safety and Security
$428,560Sze Zheng Yong · Northeastern University · · FY2022 · CSE
The Commuter Exposure Study: Linking Exposure, Source-Receptor Models, and Health
$428,439John Volckens · Colorado State University · R01 · FY2012 · ES